Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Dow Inc
DOW
|
+$123M |
| 2 |
Newmont
NEM
|
+$77.1M |
| 3 |
Corteva
CTVA
|
+$72.5M |
| 4 |
Amcor
AMCR
|
+$60.2M |
| 5 |
Alibaba
BABA
|
+$47.4M |
Top Sells
| 1 |
DuPont de Nemours
DD
|
+$101M |
| 2 |
Apple
AAPL
|
+$94.5M |
| 3 |
GG
Goldcorp Inc
GG
|
+$78.3M |
| 4 |
Microsoft
MSFT
|
+$77.6M |
| 5 |
Pfizer
PFE
|
+$53.9M |
Sector Composition
| 1 | Technology | 19.94% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 11.95% |
| 4 | Communication Services | 10.13% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Stoneridge
SRI
$232M
| $1.67M | ﹤0.01% |
53,000
+3,700
| +8% | +$117K |
|
1802
MGP Ingredients
MGPI
$603M
| $1.67M | ﹤0.01% |
25,200
+700
| +3% | +$46.4K |
|
|
TERP
1803
DELISTED
TerraForm Power, Inc
TERP
| $1.67M | ﹤0.01% |
116,691
+2,300
| +2% | +$32.9K |
|
|
WW
1804
DELISTED
WW International
WW
| $1.67M | ﹤0.01% |
87,300
+14,200
| +19% | +$271K |
|
|
LTRPA
1805
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $1.67M | ﹤0.01% |
134,252
+2,800
| +2% | +$34.7K |
|
|
EPZM
1806
DELISTED
Epizyme, Inc
EPZM
| $1.67M | ﹤0.01% |
132,700
+2,400
| +2% | +$30.1K |
|
1807
Wabash National
WNC
$472M
| $1.66M | ﹤0.01% |
102,200
| – | – |
|
1808
Chefs' Warehouse
CHEF
$2.69B
| $1.66M | ﹤0.01% |
47,400
+3,700
| +8% | +$130K |
|
1809
CorVel
CRVL
$4.53B
| $1.66M | ﹤0.01% |
57,300
+900
| +2% | +$26.1K |
|
1810
Unitil
UTL
$832M
| $1.66M | ﹤0.01% |
27,700
+600
| +2% | +$35.9K |
|
|
AAMI
1811
Acadian Asset Management Inc.
AAMI
$1.73B
| $1.66M | ﹤0.01% |
145,360
| – | – |
|
1812
Encore Capital Group
ECPG
$1.02B
| $1.65M | ﹤0.01% |
48,800
+1,000
| +2% | +$33.9K |
|
|
SLCA
1813
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $1.65M | ﹤0.01% |
129,250
-12,000
| -8% | -$153K |
|
1814
Lindsay Corp
LNN
$1.53B
| $1.65M | ﹤0.01% |
20,100
+500
| +3% | +$41.1K |
|
1815
Acushnet Holdings
GOLF
$4.47B
| $1.65M | ﹤0.01% |
62,800
+1,500
| +2% | +$39.4K |
|
1816
Madrigal Pharmaceuticals
MDGL
$9.79B
| $1.65M | ﹤0.01% |
15,700
+1,700
| +12% | +$178K |
|
|
TBI
1817
Trueblue
TBI
$176M
| $1.64M | ﹤0.01% |
74,500
+700
| +0.9% | +$15.4K |
|
1818
Coeur Mining
CDE
$9.88B
| $1.64M | ﹤0.01% |
378,300
+7,900
| +2% | +$34.3K |
|
1819
Arbor Realty Trust
ABR
$2.29B
| $1.64M | ﹤0.01% |
135,051
+2,000
| +2% | +$24.2K |
|
|
CLDT
1820
Chatham Lodging
CLDT
$354M
| $1.64M | ﹤0.01% |
86,700
+1,900
| +2% | +$35.9K |
|
1821
Columbia Financial
CLBK
$1.61B
| $1.63M | ﹤0.01% |
107,788
+23,300
| +28% | +$352K |
|
|
TRHC
1822
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $1.63M | ﹤0.01% |
32,600
+2,800
| +9% | +$140K |
|
1823
Astronics
ATRO
$1.43B
| $1.62M | ﹤0.01% |
40,255
+700
| +2% | +$28.2K |
|
1824
Hecla Mining
HL
$7.47B
| $1.62M | ﹤0.01% |
898,662
+23,500
| +3% | +$42.3K |
|
|
QUOT
1825
DELISTED
Quotient Technology Inc
QUOT
| $1.62M | ﹤0.01% |
150,600
+3,200
| +2% | +$34.4K |
|